| Advantages | They retain hallmark characteristics, including genetic mutations and protein expression signatures, making them dependable platforms for breast cancer research. |
| Species | Human |
| Product Type | Tissue-derived Organoid |
| Quality Control | Negative for mycoplasma, bacteria, yeast, and fungi. |
| Tissue | Breast |
| Disease | Breast cancer |
| Organoid Characterization | Breast cancer organoids exhibit strong pathological concordance with tumor tissues, expressing key markers including estrogen receptor (ER), progesterone receptor (PR), and HER2. |
| Applications | By preserving tumor heterogeneity and modeling the tumor microenvironment (TME), they enable in-depth investigation of disease progression and therapeutic response. As clinically relevant systems, breast cancer organoids are essential for advancing precision medicine and driving the development of more effective treatment strategies. |
| Storage | Liquid Nitrogen |
| Shipping Information | Dry Ice |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.